openPR Logo
Press release

Neurodegenerative Drugs Market 2021 Size, Status and Global Outlook - Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi

11-09-2021 04:42 AM CET | Health & Medicine

Press release from: Market Insights Reports

The "Neurodegenerative Drugs" Market report offers qualitative and quantitative insights and a detailed analysis of market size & growth rate for all possible segments in the market. The Global Neurodegenerative Drugs Industry presents a market overview, product details, classification, and market concentration. The report also provides an in-depth survey of key players in the market which is based on various competitive intelligence parameters like company profiles, product picture and specification, capacity, production, price, cost, revenue, and contact information. The Neurodegenerative Drugs Market report provides an in-depth study of SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization.

The global market for Neurodegenerative Drugs estimated at US$34.3 Billion in the year 2020, is projected to reach a revised size of US$47.8 Billion by 2027, growing at a CAGR of 4.9% over the analysis period 2020-2027.

Click here to get a Free Sample Copy of the Report: (Flat 25%)

https://www.marketinsightsreports.com/reports/01252561051/global-neurodegenerative-drugs-market-research-report-2021/inquiry?Source=TevaPharma&Mode=PD

Top Companies in the Global Neurodegenerative Drugs Market: Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi, GlaxoSmithKline, and others.

Regional Analysis:

The U.S. Market is Estimated at $9.3 Billion, While China is Forecast to Grow at 7.5% CAGR

The Neurodegenerative Drugs market in the U.S. is estimated at US$9.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.8 Billion by the year 2027 trailing a CAGR of 7.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.7% and 4.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR.

Industry News and Updates:

Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD), in the United States

JUNE 22, 2021 Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced its U.S. launch of the first generic version of twice daily PERFOROMIST®,formoterol fumarate inhalation solution, 20 mcg/2 ML, indicated to treat bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

This report segments the global Neurodegenerative Drugs market on the basis of Types is:

NMDA

SSRIs

Dopamine Inhibitors

On the basis of Application, the global Neurodegenerative Drugs market is segmented into:

Parkinson’s Disease

Huntington Disease

Amyotrophic Lateral Sclerosis

Alzheimer’s Disease

The research study evaluates the overall size of the market, by making use of a bottom-up approach, wherein data for different industry verticals, and end-user industries and its applications across various product types have been recorded and predicted during the forecast period. These segments and sub-segments have been documented from the industry specialists and professionals, as well as company representatives, and are outwardly validated by analysing previous year's data of these segments and sub-segments for getting an accurate and complete Neurodegenerative Drugs market size.

Influence of the Neurodegenerative Drugs Market Report:

-Comprehensive assessment of all opportunities and risk in the Neurodegenerative Drugs market.

-Neurodegenerative Drugs market recent innovations and major events.

-Detailed study of business strategies for growth of the Neurodegenerative Drugs market-leading players.

-Conclusive study about the growth plot of Neurodegenerative Drugs market for forthcoming years.

-In-depth understanding of Neurodegenerative Drugs market-particular drivers, constraints and major micro markets.

-Favourable impression inside vital technological and market latest trends striking the Neurodegenerative Drugs market.

For more information of this report:

https://www.marketinsightsreports.com/reports/01252561051/global-neurodegenerative-drugs-market-research-report-2021?Source=TevaPharma&Mode=PD

Table Of Content

Chapter 1 Study Coverage

Chapter 2 Executive Summary

Chapter 3 Neurodegenerative Drugs Market Competitor Landscape by Players

Chapter 4 Neurodegenerative Drugs Market Size by Type and Application

Chapter 5 Global and Regional Analysis

Chapter 6 Company Profiles

Chapter 7 Market Opportunities, Challenges, Risks and Influences Factors Analysis

Chapter 8 Value Chain and Sales Channels Analysis

Chapter 9 Research Findings and Conclusion

Chapter 10 Methodology/Research Approach

Finally, the Neurodegenerative Drugs Market report is the believable source for gaining the market research that will exponentially accelerate your business. The report gives the principal locale, economic situations with the item value, benefit, limit, generation, supply, request and market development rate and figure, and so on. Neurodegenerative Drugs industry report additionally Presents a new task SWOT examination, speculation attainability investigation, and venture return investigation.

We also offer customization on reports based on specific client requirement:

1- Free country level analysis for any 5 countries of your choice.
2- Free competitive analysis of any 5 key market players.
3- Free 40 analyst hours to cover any other data points

Please connect with our sales team (sales@marketinsightsreports.com).

Contact US:
Irfan Tamboli (Head of Sales) : Market Insights Reports
Phone: + 1704 266 3234 | Mob: +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc.MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurodegenerative Drugs Market 2021 Size, Status and Global Outlook - Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi here

News-ID: 2454638 • Views:

More Releases from Market Insights Reports

Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, Honeywell
Cold Chain Monitoring Market May See a Big Move | BlueAir, Denso, Eureka Forbes, …
Market Insights Reports published a new research publication on "Cold Chain Monitoring Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Cold Chain Monitoring market was mainly driven by the increasing R&D spending across the world. Some of the key players
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, Grupo Antolin
Outbound Logistics Market Next Big Thing | Major Giants- Draexlmaier, Faurecia, …
Market Insights Reports published a new research publication on "Outbound Logistics Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Outbound Logistics market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Smucker
Veterinary Telemedicine Market May See a Big Move | Nestle, Deuerer, The J.M. Sm …
Market Insights Reports published a new research publication on "Veterinary Telemedicine Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Veterinary Telemedicine market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in
Precision Planting Market is Set to Fly High in Years to Come
Precision Planting Market is Set to Fly High in Years to Come
Market Insights Reports published a new research publication on "Precision Planting Market Insights, to 2032" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Precision Planting market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled in

All 5 Releases


More Releases for Neurodegenerative

Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Neurodegenerative Disorder Therapeutics Market Size Growth Forecast: What to Expect by 2025? In recent times, the market size for therapeutics for neurodegenerative disorders has seen robust growth. The growth is expected to rise from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
"The Neurodegenerative Disorder Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Neurodegenerative Disorder Therapeutics Market Size and Its Estimated Growth Rate? The neurodegenerative disorder therapeutics market has shown strong growth, expected to increase from $18.53 billion in 2024 to $20.04 billion
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size? Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size? Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size? Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder
Novel Antibodies in Neurodegenerative Disease Treatment
Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, represent some of the most challenging medical conditions due to their progressive nature and lack of effective treatments. Novel antibodies are emerging as promising therapeutic agents, offering targeted and innovative approaches to slow disease progression and improve patient outcomes. This article explores the role of novel antibodies in the treatment of neurodegenerative diseases, highlighting their mechanisms of action and therapeutic potential. Download